| Identification | |
| Name: | Pyrrolidinium,3-[(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethyl-, iodide (1:1) |
| Synonyms: | Pyrrolidinium,3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, iodide (9CI);Glycopyrronium iodide |
| CAS: | 873295-32-0 |
| Molecular Formula: | C19H28 N O3 . I |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C19H28NO3.HI/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q+1;/p-1 |
| Molecular Structure: | ![(C19H28NO3.I) Pyrrolidinium,3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, iodide (9CI);Glycopyrronium iod...](https://img1.guidechem.com/chem/e/dict/170/873295-32-0.jpg) |
| Properties | |
| Specification: | Off-White Solid usageEng:A novel pharmaceutical compound based on PDE IV inhibitors; used in the treatment of respiratory complaints |
| Usage: | A novel pharmaceutical compound based on PDE IV inhibitors; used in the treatment of respiratory complaints |
| Safety Data | |
 |
|
